NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
This Quarter Return
-19.26%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$1.5B
AUM Growth
+$1.5B
(-3.5%)
Cap. Flow
+$312M
Cap. Flow
% of AUM
20.82%
Top 10 Holdings %
Top 10 Hldgs %
91.37%
Holding
30
New
1
Increased
18
Reduced
3
Closed
–
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$189M |
| 2 |
Brookfield
BN
|
$40.6M |
| 3 |
Apple
AAPL
|
$35.6M |
| 4 |
Cable One
CABO
|
$17.5M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$5.69M |
Top Sells
| 1 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$1.86M |
| 2 |
Inspire Medical Systems
INSP
|
$1.23M |
| 3 |
Milestone Pharmaceuticals
MIST
|
$651K |
Sector Composition
| 1 | Healthcare | 28.81% |
| 2 | Communication Services | 8.18% |
| 3 | Technology | 6.92% |
| 4 | Financials | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard Total Stock Market ETF
VTI
$526B
| $746M | 49.82% | 5,790,400 +1,465,200 | +34% | +$189M |
|
2
Inogen
INGN
$216M
| $183M | 12.24% | 3,549,321 | – | – |
|
|
3
Cable One
CABO
$909M
| $123M | 8.18% | 74,595 +10,648 | +17% | +$17.5M |
|
|
4
Apple
AAPL
$3.45T
| $104M | 6.92% | 407,606 +139,818 | +52% | +$35.6M |
|
|
5
Brookfield
BN
$98.3B
| $60.4M | 4.03% | 2,047,305 +1,374,653 | +204% | +$40.6M |
|
|
MORF
6
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $38.8M | 2.59% | 2,645,446 | – | – |
|
7
Mirum Pharmaceuticals
MIRM
$3.71B
| $34.2M | 2.28% | 2,445,147 | – | – |
|
|
GRTX
8
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $32.4M | 2.16% | 3,409,021 | – | – |
|
9
Akebia Therapeutics
AKBA
$833M
| $25.7M | 1.72% | 3,393,039 +293,039 | +9% | +$2.22M |
|
10
Amicus Therapeutics
FOLD
$2.34B
| $21.4M | 1.43% | 2,320,026 +2,156 | +0.1% | +$19.9K |
|
|
SPNE
11
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $14M | 0.94% | 1,715,431 +407,394 | +31% | +$3.33M |
|
|
BPMC
12
DELISTED
Blueprint Medicines
BPMC
| $13.7M | 0.91% | 234,267 +63,600 | +37% | +$3.72M |
|
13
SI-BONE Inc
SIBN
$719M
| $11.6M | 0.77% | 971,390 +78,706 | +9% | +$941K |
|
|
AERI
14
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $10.1M | 0.68% | 750,974 +80,938 | +12% | +$1.09M |
|
|
15
Inspire Medical Systems
INSP
$2.77B
| $9.32M | 0.62% | 154,622 -20,378 | -12% | -$1.23M |
|
16
Spero Therapeutics
SPRO
$116M
| $7.52M | 0.5% | 931,099 | – | – |
|
|
MYOK
17
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $7.12M | 0.48% | 151,816 +121,468 | +400% | +$5.69M |
|
18
Corvus Pharmaceuticals
CRVS
$428M
| $6.18M | 0.41% | 2,927,560 | – | – |
|
|
SILK
19
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $5.86M | 0.39% | 186,042 -58,958 | -24% | -$1.86M |
|
|
ETTX
20
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $5.76M | 0.38% | 2,181,843 | – | – |
|
|
ZGNX
21
DELISTED
Zogenix, Inc.
ZGNX
| $5.52M | 0.37% | 223,184 +187,484 | +525% | +$4.64M |
|
|
CNST
22
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $5.29M | 0.35% | +168,381 | New | +$5.29M |
|
23
Protagonist Therapeutics
PTGX
$3.67B
| $4.93M | 0.33% | 697,899 +218,825 | +46% | +$1.54M |
|
|
XENT
24
DELISTED
Intersect ENT, Inc
XENT
| $4.39M | 0.29% | 370,595 +152,886 | +70% | +$1.81M |
|
|
25
Milestone Pharmaceuticals
MIST
$156M
| $3.83M | 0.26% | 2,080,585 -353,885 | -15% | -$651K |
|